• mail us help@24marketresearch.com
  • Int'l (+1)-646-781-7170
  • UK(Toll free) +44-800-088-5734

TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Anal Cancer Therapeutics Market Size, Status and Forecast 2018-2025

Global Anal Cancer Therapeutics Market Size, Status and Forecast 2018-2025

  • Category:Life Sciences
  • Published on : 29 August 2018
  • Pages :99
  • Formats:
  • Report Code:24MRES-3055663
Click for best price

Best Price: $3120

This report focuses on the global Anal Cancer Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Anal Cancer Therapeutics development in United States, Europe and China.

A cancer can be defined when the normal cells lose their ability to control, their growth or multiplication and thus invade the tissues and spread to the body parts. Anal cancer is often called as squamous cell carcinoma which arises from the cells around or in the anal opening or in rare cases it may cause in the anal canal. This type of cancer is usually associated with human papiloma virus (HPV), where HPV cancers or cervical cancers have a high risk of developing into anal cancer. There are no exact symptoms for anal cancer as such but some might show bleeding from the anal area, lump or swelling near anus or change in the bowel habits etc.  Staging is a way which describes the location of cancer, the stages include tumor, node and metastasis which is further grouped I, II, IIIA, IIIB and IV. The different types of anal cancer include melanoma, adenocarcinoma, basaloid transitional and cloacogenic cancer.
The statistics for anal cancer suggest that annually there about 6000 cases of anal cancer diagnosed in the U.S. and the number is increasing slowly. The major factors that drive the market for anal cancer therapeutics are aging population, sexually transmitted disease, multiple sexual partners and smoking. According to the World Health Organization 290 million women are suffering from HPV infection and due to unhealthy sex, the chances get doubled. For treating this anal cancer, early diagnosis is crucial which is only available in the developed countries or high-income countries and are accessible. Whereas in the low-income countries the diagnosis and treatment facilities are either costly or inaccessible. These factors are responsible for holding back the anal cancer therapeutics market and should be well tracked for future advancements.
In 2017, the global Anal Cancer Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

The key players covered in this study
GlaxoSmithKline Pharmaceuticals
Spectrum Pharmaceuticals
Hospira
Global BioPharma
Advaxis
...

Market segment by Type, the product can be split into
Fluorouracil
Cisplatin
Carboplatin

Market segment by Application, split into
Hospitals
Long-Term Care Centers
Pharmacies
Diagnostic Laboratories

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Anal Cancer Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Anal Cancer Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Anal Cancer Therapeutics are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

TABLE OF CONTENTS

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Anal Cancer Therapeutics Market Size Growth Rate by Type (2013-2025)
1.4.2 Fluorouracil
1.4.3 Cisplatin
1.4.4 Carboplatin
1.5 Market by Application
1.5.1 Global Anal Cancer Therapeutics Market Share by Application (2013-2025)
1.5.2 Hospitals
1.5.3 Long-Term Care Centers
1.5.4 Pharmacies
1.5.5 Diagnostic Laboratories
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Anal Cancer Therapeutics Market Size
2.2 Anal Cancer Therapeutics Growth Trends by Regions
2.2.1 Anal Cancer Therapeutics Market Size by Regions (2013-2025)
2.2.2 Anal Cancer Therapeutics Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Anal Cancer Therapeutics Market Size by Manufacturers
3.1.1 Global Anal Cancer Therapeutics Revenue by Manufacturers (2013-2018)
3.1.2 Global Anal Cancer Therapeutics Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global Anal Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Anal Cancer Therapeutics Key Players Head office and Area Served
3.3 Key Players Anal Cancer Therapeutics Product/Solution/Service
3.4 Date of Enter into Anal Cancer Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Anal Cancer Therapeutics Market Size by Type (2013-2018)
4.2 Global Anal Cancer Therapeutics Market Size by Application (2013-2018)

5 United States
5.1 United States Anal Cancer Therapeutics Market Size (2013-2018)
5.2 Anal Cancer Therapeutics Key Players in United States
5.3 United States Anal Cancer Therapeutics Market Size by Type
5.4 United States Anal Cancer Therapeutics Market Size by Application

6 Europe
6.1 Europe Anal Cancer Therapeutics Market Size (2013-2018)
6.2 Anal Cancer Therapeutics Key Players in Europe
6.3 Europe Anal Cancer Therapeutics Market Size by Type
6.4 Europe Anal Cancer Therapeutics Market Size by Application

7 China
7.1 China Anal Cancer Therapeutics Market Size (2013-2018)
7.2 Anal Cancer Therapeutics Key Players in China
7.3 China Anal Cancer Therapeutics Market Size by Type
7.4 China Anal Cancer Therapeutics Market Size by Application

8 Japan
8.1 Japan Anal Cancer Therapeutics Market Size (2013-2018)
8.2 Anal Cancer Therapeutics Key Players in Japan
8.3 Japan Anal Cancer Therapeutics Market Size by Type
8.4 Japan Anal Cancer Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Anal Cancer Therapeutics Market Size (2013-2018)
9.2 Anal Cancer Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Anal Cancer Therapeutics Market Size by Type
9.4 Southeast Asia Anal Cancer Therapeutics Market Size by Application

10 India
10.1 India Anal Cancer Therapeutics Market Size (2013-2018)
10.2 Anal Cancer Therapeutics Key Players in India
10.3 India Anal Cancer Therapeutics Market Size by Type
10.4 India Anal Cancer Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Anal Cancer Therapeutics Market Size (2013-2018)
11.2 Anal Cancer Therapeutics Key Players in Central & South America
11.3 Central & South America Anal Cancer Therapeutics Market Size by Type
11.4 Central & South America Anal Cancer Therapeutics Market Size by Application

12 International Players Profiles
12.1 GlaxoSmithKline Pharmaceuticals
12.1.1 GlaxoSmithKline Pharmaceuticals Company Details
12.1.2 Company Description and Business Overview
12.1.3 Anal Cancer Therapeutics Introduction
12.1.4 GlaxoSmithKline Pharmaceuticals Revenue in Anal Cancer Therapeutics Business (2013-2018)
12.1.5 GlaxoSmithKline Pharmaceuticals Recent Development
12.2 Spectrum Pharmaceuticals
12.2.1 Spectrum Pharmaceuticals Company Details
12.2.2 Company Description and Business Overview
12.2.3 Anal Cancer Therapeutics Introduction
12.2.4 Spectrum Pharmaceuticals Revenue in Anal Cancer Therapeutics Business (2013-2018)
12.2.5 Spectrum Pharmaceuticals Recent Development
12.3 Hospira
12.3.1 Hospira Company Details
12.3.2 Company Description and Business Overview
12.3.3 Anal Cancer Therapeutics Introduction
12.3.4 Hospira Revenue in Anal Cancer Therapeutics Business (2013-2018)
12.3.5 Hospira Recent Development
12.4 Global BioPharma
12.4.1 Global BioPharma Company Details
12.4.2 Company Description and Business Overview
12.4.3 Anal Cancer Therapeutics Introduction
12.4.4 Global BioPharma Revenue in Anal Cancer Therapeutics Business (2013-2018)
12.4.5 Global BioPharma Recent Development
12.5 Advaxis
12.5.1 Advaxis Company Details
12.5.2 Company Description and Business Overview
12.5.3 Anal Cancer Therapeutics Introduction
12.5.4 Advaxis Revenue in Anal Cancer Therapeutics Business (2013-2018)
12.5.5 Advaxis Recent Development

13 Market Forecast 2018-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2018-2025)
13.10 Market Size Forecast by Application (2018-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

LIST OF TABLES & FIGURES

List of Tables and Figures

Table Anal Cancer Therapeutics Key Market Segments
Table Key Players Anal Cancer Therapeutics Covered
Table Global Anal Cancer Therapeutics Market Size Growth Rate by Type 2013-2025 (Million US$)
Figure Global Anal Cancer Therapeutics Market Size Market Share by Type 2013-2025
Figure Fluorouracil Figures
Table Key Players of Fluorouracil
Figure Cisplatin Figures
Table Key Players of Cisplatin
Figure Carboplatin Figures
Table Key Players of Carboplatin
Table Global Anal Cancer Therapeutics Market Size Growth by Application 2013-2025 (Million US$)
Figure Hospitals Case Studies
Figure Long-Term Care Centers Case Studies
Figure Pharmacies Case Studies
Figure Diagnostic Laboratories Case Studies
Figure Anal Cancer Therapeutics Report Years Considered
Table Global Anal Cancer Therapeutics Market Size 2013-2025 (Million US$)
Figure Global Anal Cancer Therapeutics Market Size and Growth Rate 2013-2025 (Million US$)
Table Global Anal Cancer Therapeutics Market Size by Regions 2013-2025 (Million US$)
Table Global Anal Cancer Therapeutics Market Size by Regions 2013-2018 (Million US$)
Table Global Anal Cancer Therapeutics Market Share by Regions 2013-2018
Figure Global Anal Cancer Therapeutics Market Share by Regions 2013-2018
Figure Global Anal Cancer Therapeutics Market Share by Regions 2018
Table Market Top Trends
Table Global Anal Cancer Therapeutics Revenue by Manufacturers (2013-2018) (Million US$)
Table Global Anal Cancer Therapeutics Market Share by Manufacturers (2013-2018)
Figure Global Anal Cancer Therapeutics Market Share by Manufacturers in 2018
Table Global Anal Cancer Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Anal Cancer Therapeutics Product/Solution/Service
Table Date of Enter into Anal Cancer Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Anal Cancer Therapeutics Market Size by Type (2013-2018) (Million US$)
Table Global Anal Cancer Therapeutics Market Size Share by Type (2013-2018)
Figure Global Anal Cancer Therapeutics Market Size Market Share by Type (2013-2018)
Table Global Anal Cancer Therapeutics Market Size by Application (2013-2018) (Million US$)
Table Global Anal Cancer Therapeutics Market Size Share by Application (2013-2018)
Figure Global Anal Cancer Therapeutics Market Size Market Share by Application (2013-2018)
Figure Global Anal Cancer Therapeutics Revenue Market Share by Application in 2017
Figure United States Anal Cancer Therapeutics Market Size 2013-2018 (Million US$)
Table United States Key Players Anal Cancer Therapeutics Revenue (2017-2018) (Million US$)
Table United States Key Players Anal Cancer Therapeutics Market Share (2017-2018)
Table United States Anal Cancer Therapeutics Market Size by Type (2013-2018) (Million US$)
Table United States Anal Cancer Therapeutics Market Share by Type (2013-2018)
Table United States Anal Cancer Therapeutics Market Size by Application (2013-2018) (Million US$)
Table United States Anal Cancer Therapeutics Market Share by Application (2013-2018)
Figure Europe Anal Cancer Therapeutics Market Size 2013-2018 (Million US$)
Table Europe Key Players Anal Cancer Therapeutics Revenue (2017-2018) (Million US$)
Table Europe Key Players Anal Cancer Therapeutics Market Share (2017-2018)
Table Europe Anal Cancer Therapeutics Market Size by Type (2013-2018) (Million US$)
Table Europe Anal Cancer Therapeutics Market Share by Type (2013-2018)
Table Europe Anal Cancer Therapeutics Market Size by Application (2013-2018) (Million US$)
Table Europe Anal Cancer Therapeutics Market Share by Application (2013-2018)
Figure China Anal Cancer Therapeutics Market Size 2013-2018 (Million US$)
Table China Key Players Anal Cancer Therapeutics Revenue (2017-2018) (Million US$)
Table China Key Players Anal Cancer Therapeutics Market Share (2017-2018)
Table China Anal Cancer Therapeutics Market Size by Type (2013-2018) (Million US$)
Table China Anal Cancer Therapeutics Market Share by Type (2013-2018)
Table China Anal Cancer Therapeutics Market Size by Application (2013-2018) (Million US$)
Table China Anal Cancer Therapeutics Market Share by Application (2013-2018)
Figure Japan Anal Cancer Therapeutics Market Size 2013-2018 (Million US$)
Table Japan Key Players Anal Cancer Therapeutics Revenue (2017-2018) (Million US$)
Table Japan Key Players Anal Cancer Therapeutics Market Share (2017-2018)
Table Japan Anal Cancer Therapeutics Market Size by Type (2013-2018) (Million US$)
Table Japan Anal Cancer Therapeutics Market Share by Type (2013-2018)
Table Japan Anal Cancer Therapeutics Market Size by Application (2013-2018) (Million US$)
Table Japan Anal Cancer Therapeutics Market Share by Application (2013-2018)
Figure Southeast Asia Anal Cancer Therapeutics Market Size 2013-2018 (Million US$)
Table Southeast Asia Key Players Anal Cancer Therapeutics Revenue (2017-2018) (Million US$)
Table Southeast Asia Key Players Anal Cancer Therapeutics Market Share (2017-2018)
Table Southeast Asia Anal Cancer Therapeutics Market Size by Type (2013-2018) (Million US$)
Table Southeast Asia Anal Cancer Therapeutics Market Share by Type (2013-2018)
Table Southeast Asia Anal Cancer Therapeutics Market Size by Application (2013-2018) (Million US$)
Table Southeast Asia Anal Cancer Therapeutics Market Share by Application (2013-2018)
Figure India Anal Cancer Therapeutics Market Size 2013-2018 (Million US$)
Table India Key Players Anal Cancer Therapeutics Revenue (2017-2018) (Million US$)
Table India Key Players Anal Cancer Therapeutics Market Share (2017-2018)
Table India Anal Cancer Therapeutics Market Size by Type (2013-2018) (Million US$)
Table India Anal Cancer Therapeutics Market Share by Type (2013-2018)
Table India Anal Cancer Therapeutics Market Size by Application (2013-2018) (Million US$)
Table India Anal Cancer Therapeutics Market Share by Application (2013-2018)
Figure Central & South America Anal Cancer Therapeutics Market Size 2013-2018 (Million US$)
Table Central & South America Key Players Anal Cancer Therapeutics Revenue (2017-2018) (Million US$)
Table Central & South America Key Players Anal Cancer Therapeutics Market Share (2017-2018)
Table Central & South America Anal Cancer Therapeutics Market Size by Type (2013-2018) (Million US$)
Table Central & South America Anal Cancer Therapeutics Market Share by Type (2013-2018)
Table Central & South America Anal Cancer Therapeutics Market Size by Application (2013-2018) (Million US$)
Table Central & South America Anal Cancer Therapeutics Market Share by Application (2013-2018)
Table GlaxoSmithKline Pharmaceuticals Company Details
Table GlaxoSmithKline Pharmaceuticals Revenue in Anal Cancer Therapeutics Business (2013-2018) (Million US$)
Figure GlaxoSmithKline Pharmaceuticals Revenue Growth Rate in Anal Cancer Therapeutics Business (2013-2018)
Table GlaxoSmithKline Pharmaceuticals Recent Development
Table Spectrum Pharmaceuticals Company Details
Table Spectrum Pharmaceuticals Revenue in Anal Cancer Therapeutics Business (2013-2018)(Million US$)
Figure Spectrum Pharmaceuticals Revenue Growth Rate in Anal Cancer Therapeutics Business (2013-2018)
Table Spectrum Pharmaceuticals Recent Development
Table Hospira Company Details
Table Hospira Revenue in Anal Cancer Therapeutics Business (2013-2018)(Million US$)
Figure Hospira Revenue Growth Rate in Anal Cancer Therapeutics Business (2013-2018)
Table Hospira Recent Development
Table Global BioPharma Company Details
Table Global BioPharma Revenue in Anal Cancer Therapeutics Business (2013-2018)(Million US$)
Figure Global BioPharma Revenue Growth Rate in Anal Cancer Therapeutics Business (2013-2018)
Table Global BioPharma Recent Development
Table Advaxis Company Details
Table Advaxis Revenue in Anal Cancer Therapeutics Business (2013-2018)(Million US$)
Figure Advaxis Revenue Growth Rate in Anal Cancer Therapeutics Business (2013-2018)
Table Advaxis Recent Development
Table Global Anal Cancer Therapeutics Market Size by Regions (Million US$) 2018-2025
Figure Global Anal Cancer Therapeutics Market Size Share by Regions (2018-2025)
Figure Global Anal Cancer Therapeutics Market Size Share by Regions in 2025
Figure United States Anal Cancer Therapeutics Market Size Forecast (2018-2025)(Million USD)
Figure Europe Anal Cancer Therapeutics Market Size Forecast (2018-2025)(Million USD)
Figure China Anal Cancer Therapeutics Market Size Forecast (2018-2025)(Million USD)
Figure Japan Anal Cancer Therapeutics Market Size Forecast (2018-2025)(Million USD)
Figure Southeast Asia Anal Cancer Therapeutics Market Size Forecast (2018-2025)(Million USD)
Figure India Anal Cancer Therapeutics Market Size Forecast (2018-2025)(Million USD)
Figure Central & South America Anal Cancer Therapeutics Market Size Forecast (2018-2025)(Million USD)
Table Global Anal Cancer Therapeutics Market Size by Product (2018-2025) (Million US$)
Figure Global Anal Cancer Therapeutics Market Size by Product (2018-2025)
Figure Global Anal Cancer Therapeutics Market Size by Product in 2025
Table Global Anal Cancer Therapeutics Market Size by Application (2018-2025) (Million US$)
Figure Global Anal Cancer Therapeutics Market Size by Application (2018-2025)
Figure Global Anal Cancer Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

SELECT A FORMAT

USD GBP EURO YEN Single User Price
USD GBP EURO YEN Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy
check discount
  BENCHMARKS  
Loading Time: Base Classes  0.0096
Controller Execution Time ( Reports Controller / Report Details )  5.1784
Total Execution Time  5.1890
  GET DATA  
No GET data exists
  MEMORY USAGE  
1,199,488 bytes
  POST DATA  
No POST data exists
  URI STRING  
life-sciences/3055663/global-anal-cancer-therapeutics-2018-2025-754
  CLASS/METHOD  
Reports_controller/report_details
  DATABASE:  chemical_common24 (Reports_controller:$db)   QUERIES: 12 (5.1571 seconds)  (Hide)
0.0001   SELECT GET_LOCK('f7e0a587231a6bb76a741460fe0456ce'300) AS ci_session_lock 
0.0201   SELECT `data`
FROM `24mresearch_ci_sessions`
WHERE `id` = '822225780bf638cfd489803b1466bda7465b62cb' 
0.0212   SELECT `24_report`.*, `24_sub_cat_1`.`sc1_name`, `24_sub_cat_1`.`sc1_url`, `24_sub_cat_1`.`sc1_status`, `24_publisher`.`publisher_name`, `24_report_metadata`.*
FROM `24_report`
LEFT JOIN `24_sub_cat_1ON `24_sub_cat_1`.`sc1_id` = `24_report`.`rep_sub_cat_1_id`
LEFT JOIN `24_publisherON `24_publisher`.`publisher_id` = `24_report`.`publisher_id`
LEFT JOIN `24_report_metadataON `24_report_metadata`.`meta_rep_id` = `24_report`.`rep_id`
WHERE `rep_status` = 'Y'
AND `rep_archive_status` = 'N'
AND `rep_date` > '2017-03-31'
AND `24_report`.`rep_id` = '3055663' 
0.0002   SELECT `sc1_id`, `sc1_url`, `sc1_name`
FROM `24_sub_cat_1`
WHERE `sc1_status` = 'Y'
ORDER BY `sc1_idAS
0.0002   SELECT *
FROM `24_report_license`
WHERE `li_rep_id` = '3055663'
AND `li_pub_id` = '1' 
5.1148   SELECT `24_report`.`rep_title`, `24_report`.`rep_id`, `24_report`.`rep_url`, `24_report`.`rep_date`, `24_sub_cat_1`.`sc1_url`, `24_sub_cat_1`.`sc1_name`
FROM `24_report`
LEFT JOIN `24_sub_cat_1ON `24_report`.`rep_sub_cat_1_id`=`24_sub_cat_1`.`sc1_id`
WHERE `rep_status` = 'Y'
AND `rep_archive_status` = 'N'
AND `rep_date` > '2017-03-31'
AND  `rep_titleLIKE '%anal cancer therapeutics%' ESCAPE '!'
 
LIMIT 4 
0.0002   SELECT FROM 24_report_currency WHERE cur_symbol 'GBP' 
0.0001   SELECT FROM 24_report_currency WHERE cur_symbol 'EUR' 
0.0001   SELECT FROM 24_report_currency WHERE cur_symbol 'JPY' 
0.0001   SELECT FROM 24_report_currency WHERE cur_symbol 'GBP' 
0.0001   SELECT FROM 24_report_currency WHERE cur_symbol 'EUR' 
0.0001   SELECT FROM 24_report_currency WHERE cur_symbol 'JPY' 
  HTTP HEADERS  (Show)
  SESSION DATA  (Show)
  CONFIG VARIABLES  (Show)